Evaluation of Human Papillomavirus Vaccination and Cancer Prevention Behaviors among LGBTQI + Individuals: A Cross-Sectional Study.
Human Papillomavirus (HPV) vaccination and cervical cancer screening rates are suboptimal in the US, particularly among historically underserved groups like Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex (LGBTQI+)-identifying women and transgender men. Therefore, our cross-sectional study...
| Published in: | Journal of Community Health Vol. 50; no. 1; pp. 98 - 111 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Article |
| Published: |
Springer Nature
Feb2025
|
| Subjects: | |
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=182882941&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 182882941 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00945145 JCH jtl: Journal of Community Health issn: 00945145 maglogo: N pubinfo: dt: Feb2025 vid: 50 iid: 1 pid: 237 pub: Springer Nature artinfo: ui: 182882941 10.1007/s10900-024-01401-1 ppf: 98 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P size: 1.3MB tig: atl: Evaluation of Human Papillomavirus Vaccination and Cancer Prevention Behaviors among LGBTQI + Individuals: A Cross-Sectional Study. aug: au: Rana, Sanjana K. Perkins, Rebecca B. Carr, Devan Feldman, Sarah Welch, Kelly Duffey-Lind, Eileen Villa, Alessandro affil: Team Maureen, North Falmouth, MA, USA https://ror.org/05qwgg493 Department of Obstetrics and Gynecology, Boston University Chobanian and Avdesian School of Medicine and Boston Medical Center Cancer Center, Boston, MA, USA https://ror.org/02jzgtq86 Community Benefits Office, Dana-Farber Cancer Institute, Boston, MA, USA https://ror.org/03vek6s52 Division of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA https://ror.org/02jzgtq86 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA https://ror.org/00v47pv90 Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, 8900 North Kendall Drive, 33176, Miami, FL, USA su: Immunization Cross-sectional method Gender identity Insurance LGBTQ+ people Papillomavirus diseases Cervix uteri tumors Research funding Early detection of cancer Human papillomavirus vaccines Descriptive statistics Odds ratio Confidence intervals Gynecologic examination Vaccination status sug: subj: Immunization Cross-sectional method Gender identity Insurance LGBTQ+ people Other Insurance Funds Third Party Administration of Insurance and Pension Funds All Other Insurance Related Activities Papillomavirus diseases Cervix uteri tumors Research funding Early detection of cancer Human papillomavirus vaccines Descriptive statistics Odds ratio Confidence intervals Gynecologic examination Vaccination status keyword: Cancer screening Human papillomavirus LGBTQI+ Medical and Health Sciences Public Health and Health Services Vaccine Cancer screening Human papillomavirus LGBTQI+ Medical and Health Sciences Public Health and Health Services Vaccine ab: Human Papillomavirus (HPV) vaccination and cervical cancer screening rates are suboptimal in the US, particularly among historically underserved groups like Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex (LGBTQI+)-identifying women and transgender men. Therefore, our cross-sectional study assessed factors associated with these rates among LGBTQI+-identifying women and transgender men. HPV-related cancer knowledge, HPV vaccination and cervical cancer screening status, and the acceptability of self-collection for screening of 1983 LGBTQI+-identifying women and transgender men was assessed via an online survey available to members of the HER mobile app from March to May 2022. Associations between sociodemographic factors, vaccination, and screening were assessed using multivariable logistic regressions from November 2022 to December 2023. Most participants aged 18–26 (77.0%) and 6.3% of participants aged ≥46 (P < 0.001) had received at least one dose of the HPV vaccine. Cervical cancer screening rates were positively associated with age: 70.5% of those aged 21–26 and 96.1% aged ≥46 (P < 0.001). Screening was negatively associated with male gender identity (OR, 0.13; 95% CI, 0.04–0.42; P < 0.001), being uninsured (OR, 0.40; 95% CI, 0.24–0.67; P < 0.001), and being unvaccinated against HPV (OR, 0.28; 95% CI, 0.18–0.43; P < 0.001). 29.6% of those unscreened believed screening was not needed, and 22.1% were uncomfortable with pelvic exams. 40.4% of all participants would prefer self-collection for screening. Our findings indicate opportunities to increase screening and vaccination. Among under-screened individuals, lack of knowledge about screening necessity and discomfort with pelvic exams were important barriers. Targeted interventions addressing patient knowledge, practitioner communication, and exploring self-screening strategies are warranted. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|